Abstract
Severity Evaluation Indexes are very useful instruments for the assessment of a patient with nail psoriasis. Their role is essential in clinical trials, baseline consultation, therapeutic strategy, and consequent follow-up. Therefore, they should be objective, reproducible, and simple to perform.
Various parameters are taken into account such as localization of the inflammatory process, polymorphism of clinical findings, disease extent, and quality of life impairment. In order to assess disease severity, studies have either focused on one specific clinical sign or have tried to combine multiple features to improve their validity. Qualitative assessment is quicker but, on the other hand, grades subjectively the severity of each feature. Numeric or quantitative evaluation is more objective but is more time-consuming.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tosti A, Piraccini BM, Cameli N, Kokely F, Plozzer C, Cannata GE, et al. Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid. Br J Dermatol. 1998;139:655–9.
Pierard GE, Pierard-Franchmimont C. Dynamics of psoriatic trachyonychia during low-dose cyclosporin A treatment: a pilot study on onychochronobiology using optical profilometry. Dermatology. 1996;192:116–9.
Rich P, Scher R. Nail psoriasis severity index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003;49:206–12.
Rigopoulos D, Gregoriou S, Makris M, et al. Efficacy of Ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with Ustekinumab for cutaneous psoriasis: an open prospective unblinded study. Dermatology. 2011;223(4):325–9.
Tosti A, Ricotti C, Romanelli P, et al. Evaluation of the efficacy of Acitretin therapy for nail psoriasis. Arch Dermatol. 2009;145(3):269–71.
Bianchi L, Bergamin A, de Felice C, et al. Remission and time of resolution of nail psoriasis during Infliximab therapy. J Am Acad Dermatol. 2005;52(4):736–7.
Bardazzi F, Antonucci VA, Tengattini V, et al. A 36-week retrospective open trial comparing the efficacy of biological therapies in nail psoriasis. J Dtsch Dermatol Ges. 2013;11(11):1065–70.
Cassell SE et al. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol. 2007;34:123–9.
Aktan S, Ilknur T, Akin C, et al. Interobserver reliability of the Nail Psoriasis Severity Index. Clin Exp Dermatol. 2007;32:141–4.
Parrish CA, Sobera JO, Elewski BO. Modification of Nail Psoriasis Severity Index. J Am Acad Dermatol. 2005;53(4):745–6; author reply 746–7.
Rich P, Scher R. Modifications of the Nail Psoriasis Severity Index [authors reply]. J Am Acad Dermatol. 2005;53:746–7.
van der Velden HM, Klaassen KM, van de Kerkhof PC, et al. Fingernail psoriasis reconsidered: a case-control study. J Am Acad Dermatol. 2013;69:245–52.
Garzitto A, Ricceri R, Trip L, et al. Possible reconsideration of the Nail Psoriasis Severity Index (NAPSI) score. J Am Acad Dermatol. 2013;69(6):1053–4.
Kacar N, Ergin S, Erdogan B. The comparison of Nail Psoriasis Severity Index with a less time-consuming qualitative system. J Eur Acad Dermatol Venereol. 2008;22:219–22.
Augustin M, Blome C, Costanzo A, et al. Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. Br J Dermatol. 2014;170(3):591–8.
Baran RL. A nail psoriasis severity index. Br J Dermatol. 2004;150:568–9.
Cannavò SP, Guarneri F, Vaccaro M, et al. Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study. Dermatology. 2003;206:153–6.
Rich P, Bourcier M, Sofen H, et al. The PHOENIX 1 Investigators. Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1. Br J Dermatol. 2014;170(2):398–407.
Ortonne JP, Baran R, Corvest M, et al. Development and validation of nail psoriasis quality of life scale (NPQ10). J Eur Acad Dermatol Venereol. 2010;24:22–7.
Augustin M, Ogilvie A. Methods of outcomes measurement in nail psoriasis. Dermatology. 2010;221 Suppl 1:23–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Rigopoulos, D., Prevezas, C. (2014). Severity Evaluation Indexes. In: Rigopoulos, D., Tosti, A. (eds) Nail Psoriasis. Springer, Cham. https://doi.org/10.1007/978-3-319-08810-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-08810-5_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-08809-9
Online ISBN: 978-3-319-08810-5
eBook Packages: MedicineMedicine (R0)